Results 81 to 90 of about 35,587 (239)
Background: Chemotherapy inducing nausea and vomiting (CINV) is one of the significant side effects of anti-cancer treatment, and its full prevention is a potential challenge.
Atefe Khani +4 more
doaj
Effect of Ginger Intake on Chemotherapy- Induced Nausea and Vomiting among Patients with Bladder Cancer [PDF]
Background: Chemotherapy-induced nausea and vomiting (CINV) is constitutes a major challange for patients with bladder cancer, frequently inadequately controlled by standared antiematic, ginger has historically been explored as an adjunctive therapy to ...
Sarah Mahmoud Ahmed Boriqa +3 more
doaj +1 more source
A phase IIa study of the anti‐PD‐L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL‐T trial
The AVAIL‐T study, the first evaluation of programmed death ligand 1 (PD‐L1) blockade in relapsed/refractory peripheral T‐cell lymphomas (PTCL), demonstrated limited single agent activity with durable responses seen in a minority. Circulating tumour DNA revealed distinct mutational dynamics and mass cytometry identified perturbed T‐cell subsets ...
Matthew J. Ahearne +28 more
wiley +1 more source
Ice massage on chemotherapy induced nausea and vomiting
Background and Aim: Nausea and vomiting are the most common side effects of chemotherapy. The aim of the current study was to assess the effect of ice massage applied to the pericardium 6 (P6 or Neigaun) acupuncture point on nausea– vomiting due to
Mehdi Sadeghi Shermeh +3 more
doaj
Effect of Peppermint Inhalation on Chemotherapy Induced-Nausea and Vomiting in Children with Leukemia [PDF]
Background: Today, leukemia is one of the most important health challenges in the world. Despite the many advances in malignancy treatment, children undergoing chemotherapy are still suffering from deliberating side effects. So, pediatric oncology nurses
Eman Arafa Badr +3 more
doaj +1 more source
Targeting KRAS for cancer therapy
In recent years, therapeutics targeted against KRAS proto‐oncogene GTPase (KRAS)‐mutant cancers have seen significant progress. Herein we outline the biology and epidemiology of KRAS alterations at the lineage and allele levels, reviewing the clinical evidence for KRASG12C inhibition from the discovery of the recessive switch pocket to sotorasib ...
Jianlong Jia +4 more
wiley +1 more source
The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance.
Ines Martinez‐Corral +3 more
wiley +1 more source
ABSTRACT Objectives Pediatric acute myeloid leukemia (AML) chemotherapy regimens are frequently burdened by fever episodes, systemic inflammation and bloodstream infections (BSI). Mucosal barrier injury may contribute to these complications, but its role in childhood AML remains uninvestigated.
Carla Warley Kjær +8 more
wiley +1 more source
Chemotherapy-related nausea and vomiting - past reflections, present practice and future management
Although much progress has occurred in the last decade regarding the management of chemotherapy-induced nausea and vomiting, these remain among the most intolerable side-effects of treatment and patients continue to report the negative impact such ...
M. MILLER +3 more
core +1 more source
This is a retrospective review of intestinal tract biopsies from patients treated with various cellular immunotherapies (BCMA and CD19‐directed CAR T, teclistamab and rituximab therapies). We found distinct but overlapping histologic patterns across treatment groups, with lamina propria plasma cell depletion, crypt apoptotic bodies and active ...
Olivia J Leung +7 more
wiley +1 more source

